Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1960 2
1961 1
1962 1
1966 2
1968 2
1969 1
1970 2
1971 2
1972 2
1973 2
1974 1
1975 1
1978 1
1980 4
1981 2
1986 2
1987 1
1988 1
1989 6
1990 6
1991 2
1992 6
1993 5
1994 1
1995 6
1996 6
1997 4
1998 3
1999 5
2000 7
2001 11
2002 11
2003 9
2004 17
2005 22
2006 25
2007 20
2008 19
2009 20
2010 28
2011 25
2012 30
2013 30
2014 27
2015 30
2016 23
2017 25
2018 28
2019 29
2020 27
2021 27
2022 21
2023 21
2024 15
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

586 results

Results by year

Filters applied: . Clear all
Page 1
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS. Herbst RS, et al. Among authors: gordon ms. Nature. 2014 Nov 27;515(7528):563-7. doi: 10.1038/nature14011. Nature. 2014. PMID: 25428504 Free PMC article. Clinical Trial.
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.
Corcoran RB, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Middleton G, Muro K, Gordon MS, Tabernero J, Yaeger R, O'Dwyer PJ, Humblet Y, De Vos F, Jung AS, Brase JC, Jaeger S, Bettinger S, Mookerjee B, Rangwala F, Van Cutsem E. Corcoran RB, et al. Among authors: gordon ms. Cancer Discov. 2018 Apr;8(4):428-443. doi: 10.1158/2159-8290.CD-17-1226. Epub 2018 Feb 5. Cancer Discov. 2018. PMID: 29431699 Free PMC article. Clinical Trial.
The nature of the chemical bond.
Dunning TH Jr, Gordon MS, Xantheas SS. Dunning TH Jr, et al. Among authors: gordon ms. J Chem Phys. 2023 Apr 7;158(13):130401. doi: 10.1063/5.0148500. J Chem Phys. 2023. PMID: 37031137 No abstract available.
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.
Bullock AJ, Schlechter BL, Fakih MG, Tsimberidou AM, Grossman JE, Gordon MS, Wilky BA, Pimentel A, Mahadevan D, Balmanoukian AS, Sanborn RE, Schwartz GK, Abou-Alfa GK, Segal NH, Bockorny B, Moser JC, Sharma S, Patel JM, Wu W, Chand D, Rosenthal K, Mednick G, Delepine C, Curiel TJ, Stebbing J, Lenz HJ, O'Day SJ, El-Khoueiry AB. Bullock AJ, et al. Among authors: gordon ms. Nat Med. 2024 Sep;30(9):2558-2567. doi: 10.1038/s41591-024-03083-7. Epub 2024 Jun 13. Nat Med. 2024. PMID: 38871975 Free PMC article. Clinical Trial.
Many-Body Dispersion.
Xu P, Alkan M, Gordon MS. Xu P, et al. Among authors: gordon ms. Chem Rev. 2020 Nov 25;120(22):12343-12356. doi: 10.1021/acs.chemrev.0c00216. Epub 2020 Nov 9. Chem Rev. 2020. PMID: 33166127
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody.
Farwell MD, Gamache RF, Babazada H, Hellmann MD, Harding JJ, Korn R, Mascioni A, Le W, Wilson I, Gordon MS, Wu AM, Ulaner GA, Wolchok JD, Postow MA, Pandit-Taskar N. Farwell MD, et al. Among authors: gordon ms. J Nucl Med. 2022 May;63(5):720-726. doi: 10.2967/jnumed.121.262485. Epub 2021 Aug 19. J Nucl Med. 2022. PMID: 34413145 Free PMC article. Clinical Trial.
Intramolecular hydrogen bonding analysis.
Harville T, Gordon MS. Harville T, et al. Among authors: gordon ms. J Chem Phys. 2022 May 7;156(17):174302. doi: 10.1063/5.0090648. J Chem Phys. 2022. PMID: 35525666
Introduction: Calculations on Large Systems.
Gordon MS, Slipchenko LV. Gordon MS, et al. Chem Rev. 2015 Jun 24;115(12):5605-6. doi: 10.1021/acs.chemrev.5b00285. Chem Rev. 2015. PMID: 26104040 No abstract available.
Publications of Mark S. Gordon.
Gordon MS. Gordon MS. J Phys Chem A. 2017 Apr 13;121(14):2721-2739. doi: 10.1021/acs.jpca.7b00176. J Phys Chem A. 2017. PMID: 28403617 No abstract available.
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.
Kim TW, Bedard PL, LoRusso P, Gordon MS, Bendell J, Oh DY, Ahn MJ, Garralda E, D'Angelo SP, Desai J, Hodi FS, Wainberg Z, Delord JP, Cassier PA, Cervantes A, Gil-Martin M, Wu B, Patil NS, Jin Y, Hoang T, Mendus D, Wen X, Meng R, Cho BC. Kim TW, et al. Among authors: gordon ms. JAMA Oncol. 2023 Nov 1;9(11):1574-1582. doi: 10.1001/jamaoncol.2023.3867. JAMA Oncol. 2023. PMID: 37768658 Free PMC article.
586 results